Molecular Quality Controls Market

Request for customization Inquire Before Buying

Molecular Quality Controls Market, By Product Type (Independent Controls, Instrument-specific Controls), By Analyte type (Single-analyte Controls, Multi-analyte Controls), By Application (Infectious Diseases Diagnostics, Oncology Testing, Genetic Testing), And By End User (Diagnostic Laboratories, Hospitals, IVD Manufacturers & CROs) - Forecast Year 2024 – 2031

Healthcare // In-vitro Diagnostics

Number of Pages: 214 Report Format: pdf Report ID: ZBA-216 Publishing Date: - June, 2022

Frequently Ask Question

The Global Molecular Quality Controls Market Is Forecasted To Grow At A Rate Of 6.3% To USD 258.23 Million In 2029.

Key Factors That Are Driving The Market Growth Include Increasing number of accredited clinical laboratories, Growing adoption of third-party quality controls, Increasing government funding to support genomics projects

The Molecular Quality Controls Market Is Led By Independent Controls Segment And Is Projected To Account For The Largest Size Of The Molecular Quality Controls Market From 2022 To 2029.

Some Key Players Operating In The Molecular Quality Controls Market Include LGC Limited, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Microbiologics, Inc., Abbott Laboratories, Roche Diagnostics, Zeptometrix, LLC, Quidel Corporation, Qnostics, Maine Molecular Quality Controls, Inc., Randox Laboratories Ltd., Bio-Techne Corporation, Fortress Diagnostics, Microbix Biosystems, Grifols, S.A., Ortho Clinical Diagnostics, Anchor Molecular, Speedx Pty. Ltd., Sero AS, Seegene Inc.